← Leaderboards
Sriram Ravindran
University Of Illinois At Chicago
$3,008,157
Attributed
$6,796,175
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,796,175 · 4
By mechanism
R01$6,396,675 · 3
R56$399,500 · 1
Top collaborators
- Praveen Gajendrareddy11 shared
- Steven Roth7 shared
- Lyndon F Cooper5 shared
- Satish B Alapati1 shared
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Anne George$13,620,882
- Satish B Alapati$882,788
- Praveen Gajendrareddy$1,976,855
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsEngineeringMesenchymal Stem CellsIn VivoPlayLaboratoriesStem CellsNatural RegenerationMicrornasPreventIn VitroGenerationsImmune ResponseClinical TranslationMediatingPropertyEventNanovesicleAnti-Inflammatory AgentsInflammationInflammatoryBiomimeticsExtracellular VesiclesPathway Interactions
Grant awards (19)
3D Encapsulation, Bioprinting and Controlled Delivery of Functionally Engineered EVs (FEEs)$474,057
R01 · FY2025 · DE · contact PI
Mesenchymal stem cell extracellular vesicles for ischemic retinal damage$449,165
R01 · FY2025 · EY
Mesenchymal stem cell extracellular vesicles for ischemic retinal damage$480,304
R01 · FY2024 · EY
3D Encapsulation, Bioprinting and Controlled Delivery of Functionally Engineered EVs (FEEs)$464,577
R01 · FY2024 · DE · contact PI
Mesenchymal stem cell extracellular vesicles for ischemic retinal damage$34,369
R01 · FY2024 · EY
Mesenchymal stem cell extracellular vesicles for ischemic retinal damage$480,304
R01 · FY2023 · EY
3D Encapsulation, Bioprinting and Controlled Delivery of Functionally Engineered EVs (FEEs)$474,057
R01 · FY2023 · DE · contact PI
Mesenchymal stem cell extracellular vesicles for ischemic retinal damage$51,555
R01 · FY2023 · EY
Mesenchymal stem cell extracellular vesicles for ischemic retinal damage$17,186
R01 · FY2023 · EY
Mesenchymal stem cell extracellular vesicles for ischemic retinal damage$491,224
R01 · FY2022 · EY
3D Encapsulation, Bioprinting and Controlled Delivery of Functionally Engineered EVs (FEEs)$462,193
R01 · FY2022 · DE · contact PI
Functional Activation and Targeting of Exosomes for Regenerative Medicine$375,965
R01 · FY2022 · DE · contact PI
3D Encapsulation, Bioprinting and Controlled Delivery of Functionally Engineered EVs (FEEs)$464,702
R01 · FY2021 · DE · contact PI
Functional Activation and Targeting of Exosomes for Regenerative Medicine$379,763
R01 · FY2021 · DE · contact PI
Functional Activation and Targeting of Exosomes for Regenerative Medicine$379,763
R01 · FY2020 · DE · contact PI
Functional Activation and Targeting of Exosomes for Regenerative Medicine$379,763
R01 · FY2019 · DE · contact PI
Functional Activation and Targeting of Exosomes for Regenerative Medicine$157,965
R01 · FY2019 · DE · contact PI
Functional Activation and Targeting of Exosomes for Regenerative Medicine$379,763
R01 · FY2018 · DE · contact PI
ECM MEDIATED DENTAL PULP TISSUE REGENERATION$399,500
R56 · FY2014 · DE · contact PI